1. Home
  2. THRY vs PEPG Comparison

THRY vs PEPG Comparison

Compare THRY & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.92

Market Cap

170.3M

Sector

Industrials

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.49

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
PEPG
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
121.7M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
THRY
PEPG
Price
$3.92
$1.49
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$9.33
$11.17
AVG Volume (30 Days)
1.0M
836.8K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
25.61
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$1.01
52 Week High
$14.28
$7.80

Technical Indicators

Market Signals
Indicator
THRY
PEPG
Relative Strength Index (RSI) 58.19 35.98
Support Level $3.14 $1.32
Resistance Level $4.17 $5.37
Average True Range (ATR) 0.30 0.12
MACD 0.01 0.05
Stochastic Oscillator 68.34 27.78

Price Performance

Historical Comparison
THRY
PEPG

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: